Skip to content

Liverpool Care Pathway for the Dying at Residential Care Homes

Liverpool Care Pathway for the Dying at Residential Care Homes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01428206
Enrollment
260
Registered
2011-09-02
Start date
2009-06-30
Completion date
2012-12-31
Last updated
2013-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-of-life Care

Keywords

palliative care, nursing homes, Liverpool care pathway

Brief summary

Liverpool Care Pathway for the dying patient (LCP) was developed to transfer the care practice from the hospice setting to the hospital setting in UK. LCP is a pathway with standardized registration method to monitor the care and its results. The primary aim is to study the effects of LCP on dying patients symptom burden and communication with close relatives and health care professionals.

Detailed description

All residential care homes in Skellefteå municipality are included in the study and randomized either to control or intervention group. During the baseline period the care is provided as usual. During the intervention period the LCP is used for patients for whom the dying phase is diagnosed in the intervention group. Usual care is performed for the control group. After death of a patient a close relative fill in a questionnaire.

Interventions

OTHERLiverpool care pathway

Liverpool care pathway is started tha last day in life for elderly at nursing homes

Sponsors

Umeå University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* nursing homes in Skellefteå municipality, Sweden

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
quality of careone month to six months after the relatives deathchanges between the groups about values of symptom scores on the Edmonton assessment scale (ESAS) and the views of informal carers-evaluation of services (VOICES)assessed by close relative

Secondary

MeasureTime frameDescription
place of deaththe time of deathchanges between the groups
drug consumptionthe last three days before death

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026